Viewing StudyNCT00003809



Ignite Creation Date: 2024-05-05 @ 11:20 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00003809
Status: COMPLETED
Last Update Posted: 2023-06-22
First Post: 1999-11-01

Brief Title: Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Sponsor: Eastern Cooperative Oncology Group
Organization: Eastern Cooperative Oncology Group

Conditions & Keywords Data

Conditions:
Name
Head and Neck Cancer
Keywords:
Name View
untreated metastatic squamous neck cancer with occult primary View
recurrent metastatic squamous neck cancer with occult primary View
stage III squamous cell carcinoma of the lip and oral cavity View
stage IV squamous cell carcinoma of the lip and oral cavity View
recurrent squamous cell carcinoma of the lip and oral cavity View
stage III squamous cell carcinoma of the oropharynx View
stage IV squamous cell carcinoma of the oropharynx View
recurrent squamous cell carcinoma of the oropharynx View
stage III squamous cell carcinoma of the hypopharynx View
stage IV squamous cell carcinoma of the hypopharynx View
recurrent squamous cell carcinoma of the hypopharynx View
stage III squamous cell carcinoma of the larynx View
stage IV squamous cell carcinoma of the larynx View
recurrent squamous cell carcinoma of the larynx View
stage III squamous cell carcinoma of the paranasal sinus and nasal cavity View
stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity View
recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity View